Table 2.
Open in new tab

Results of Statistical Analysis of Percentage AMs CD8+ for Groups of Patients with Significant Difference in Mann-Whitney Criterion

% AMs CD8+ From CD45RA+P, Mann-Whitney CriterionAUC ROC AnalysisOptimal Cutoff, ROC Analysis, %
Primary EBV vs EBV reactivation<.00010.814.6
Primary EBV vs EBV reactivation and no EBV<.00010.844.6
Primary EBV with protracted recovery vs primary EBV.020.747.4
% AMs CD8+ From CD45RA+P, Mann-Whitney CriterionAUC ROC AnalysisOptimal Cutoff, ROC Analysis, %
Primary EBV vs EBV reactivation<.00010.814.6
Primary EBV vs EBV reactivation and no EBV<.00010.844.6
Primary EBV with protracted recovery vs primary EBV.020.747.4

Abbreviations: AM, atypical mononuclear cell; AUC, area under the curve; EBV, Epstein-Barr virus; ROC, receiver operating characteristic.

Table 2.
Open in new tab

Results of Statistical Analysis of Percentage AMs CD8+ for Groups of Patients with Significant Difference in Mann-Whitney Criterion

% AMs CD8+ From CD45RA+P, Mann-Whitney CriterionAUC ROC AnalysisOptimal Cutoff, ROC Analysis, %
Primary EBV vs EBV reactivation<.00010.814.6
Primary EBV vs EBV reactivation and no EBV<.00010.844.6
Primary EBV with protracted recovery vs primary EBV.020.747.4
% AMs CD8+ From CD45RA+P, Mann-Whitney CriterionAUC ROC AnalysisOptimal Cutoff, ROC Analysis, %
Primary EBV vs EBV reactivation<.00010.814.6
Primary EBV vs EBV reactivation and no EBV<.00010.844.6
Primary EBV with protracted recovery vs primary EBV.020.747.4

Abbreviations: AM, atypical mononuclear cell; AUC, area under the curve; EBV, Epstein-Barr virus; ROC, receiver operating characteristic.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close